ArticleBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation2016

Variable Eculizumab Clearance Requires Pharmacodynamic Monitoring to Optimize Therapy for Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation.

Sonata Jodele et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.